Published in Blood Weekly, November 18th, 2004
The Phase II grant follows successful completion of work under an earlier Phase I grant, and will support design, fabrication, testing and characterization of a pilot-scale bioreactor and its integration into the biopharmaceutical production process.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.